Cargando…
Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
Current tools for cardiovascular disease (CVD) risk assessment in asymptomatic individuals are imperfect. Preventive measures aimed only at individuals deemed high risk by current algorithms neglect large numbers of low-risk and intermediate-risk individuals who are destined to develop CVD and who w...
Autor principal: | Daniels, Lori B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894089/ https://www.ncbi.nlm.nih.gov/pubmed/20672100 http://dx.doi.org/10.1007/s12170-010-0078-8 |
Ejemplares similares
-
Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008) -
NATRIURETIC PEPTIDE SYSTEM AND CARDIOVASCULAR DISEASE
por: Federico, Cacciapuoti
Publicado: (2010) -
Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017) -
Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
por: deFilippi, Christopher R, et al.
Publicado: (2015) -
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
por: Natriuretic Peptides Studies Collaboration
Publicado: (2016)